avapro has been researched along with Cirrhoses, Experimental Liver in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bridle, KR | 1 |
| Sobbe, AL | 1 |
| de Guzman, CE | 1 |
| Santrampurwala, N | 1 |
| Jaskowski, LA | 1 |
| Clouston, AD | 1 |
| Campbell, CM | 1 |
| Nathan Subramaniam, V | 1 |
| Crawford, DH | 1 |
1 other study available for avapro and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Lack of efficacy of mTOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2⁻/⁻ mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; ATP Bind | 2015 |